BSEInsider Trading / SAST1 Oct 2026 · 1 Oct 2026, 08:56 am
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fosun Pharma Industrial Pte Ltd
Gland Pharma Ltd · 543245
✦ AI SummaryPromoter Reclassif.
Fosun Pharma Industrial Pte Ltd has made a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, indicating a potential change in control or significant stake acquisition in Gland Pharma Ltd.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern5/10
Regulatory Risk8/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gland Pharma Ltd - 543245 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011